Veeva Systems

Veeva Systems Inc. is an American cloud-computing company focused on pharmaceutical and life sciences industry applications.[1] Headquartered in Pleasanton, California, it was founded in 2007 by Peter Gassner and Matt Wallach.[2] It works with software as a service (SaaS) in the global life-science industry.[3]

Veeva Systems Inc.
Public
Traded asNYSE: VEEV (Class A)
Russell 1000 Component
IndustrySoftware
Founded2007
FounderPeter Gassner
Matt Wallach
Headquarters
Pleasanton, California
,
United States
Key people
Peter Gassner, Co-founder and CEO
Revenue
  • US$ 1.1 billion
  • (FY JAN 31 2020)
Websiteveeva.com

The company went public in 2013.[4] As of June 25, 2020, it had a market capitalization of US$35 billion.[5]

Acquisitions

In 2015, Veeva acquired Zinc Ahead, a content management software company.[6]

In 2019, Veeva acquired Crossix, a privacy-safe patient data and analytics company.[7]

gollark: And Python.
gollark: Or Haskell.
gollark: `// This comment is a comment`
gollark: I was mostly looking for suggestions for stuff to add to make this a bit less, I don't know, empty.
gollark: All hail compact machines.

References
  1. Kerry A. Dolan (2013-11-06). "Veeva Systems' CEO On Why Pharma Needs His Cloud Software". Forbes Magazine. Retrieved 2016-04-12.
  2. Nicholas Basta (2016-03-10). "A Conversation with Matt Wallach, Veeva Systems". Pharmaceutical Commerce. Retrieved 2016-04-12.
  3. "Meet Our Partners - Ardent". www.ardentisys.com.
  4. "Emergence VC Ritter on why he raised only a third of $1B he could have". bizjournals.com. 2015-02-11. Retrieved 2017-07-05.
  5. "Veeva Systems Inc. Class A Common Stock (VEEV) Quote & Summary Data". nasdaq.com. 2020-06-25. Retrieved 2020-06-25.
  6. "Veeva scoops up rival Zinc Ahead to create mega-content management platform" (Press release). fiercepharma.com. 2015-10-05. Retrieved 2017-07-05.
  7. "Veeva to Acquire Crossix, the Leader in Privacy-Safe Patient Data and Analytics – Crossix". Retrieved 2019-10-02.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.